Werner Witt

Title: Werner Witt: Innovator in Thrombosis Treatment

Introduction

Werner Witt is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of thrombosis treatment, holding a total of 3 patents. His work focuses on innovative combinations of therapeutic agents that address thrombotic and thromboembolic syndromes.

Latest Patents

Witt's latest patents include groundbreaking formulations such as prostacyclins, their analogs, and thromboxane receptor antagonists. One of his notable inventions is a combination product that contains a prostaglandin, prostacyclin, or a prostacyclin analog along with a thromboxane receptor antagonist. This combination is particularly suitable for joint application in treating thrombotic and thromboembolic syndromes. Another significant patent involves the use of a fibrinolytic combined with a prostacyclin analogue, which is highly effective in thrombosis treatment, especially in preventing subsequent rethrombosis.

Career Highlights

Throughout his career, Werner Witt has worked with prominent companies, including Schering Aktiengesellschaft. His innovative approaches have led to advancements in medical treatments that benefit patients suffering from thrombosis-related conditions.

Collaborations

Witt has collaborated with esteemed colleagues such as Berthold Baldus and Bernd Muller, contributing to the development of effective therapeutic solutions.

Conclusion

Werner Witt's contributions to thrombosis treatment through his patents and collaborations highlight his role as a significant innovator in the medical field. His work continues to influence the development of effective therapies for thrombotic conditions.